Description
A potent agonist of neuronal α4β2 subunit-containing nAChRs (Ki = 37 pM in a radioligand binding assay); selective for neuronal nAChRs over neuromuscular α1β1δγ subunit-containing nAChRs (Ki = 10,000 nM), α1B-, α2B-, and α2C-adrenergic receptors (Kis = 890, 597, and 342 nM, respectively), and 70 other receptors, enzymes and transporters (Kis = >1,000 nM) in radioligand binding assays; induces [86Rb+] efflux in K177 cells transfected with human neuronal α4β2 subunit-containing nAChRs (EC50 = 140 nM); increases latency to paw withdrawal in a hot-plate test in rats at 0.05 and 0.01 mg/kg; induces hypothermia, seizures, and an increase in blood pressure in rats
Formal name: 5-[(2R)-2-azetidinylmethoxy]-2-chloro-pyridine, monohydrochloride
Synonyms: Ebanicline|Tebanicline
Molecular weight: 235.1
CAS: 203564-54-9
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Ion Channel Modulation||Research Area|Neuroscience|Pain Research